University of Melbourne Elisabeth Murdoch Building - G06
Spencer Rd, Parkville VIC 3052
In keeping with our previous initiatives to optimise antimicrobial use, we are offering a seminar on Optimised treatment of mycobacterial infections
Delivered on Wednesday February 26 2020 in Melbourne, the lecture driven seminar will be suitable for infectious and intensive care physicians, public health physicians, respiratory physicians, pharmacists, nurses and others interested in antimicrobial optimisation and minimising the impact of antimicrobial resistance (AMR).
Treatment of mycobacterial infections remains a major challenge for the healthcare community with the requirement for long multi-drug regimens with a high likelihood of toxicity. Patients may have a predisposition to difficult-to-predict pharmacokinetics (e.g. paediatrics, cystic fibrosis patients) or be based in rural and regional areas where patient monitoring is more difficult than in a metropolitan setting. With new research trials underway, but also new data emerging on susceptibility testing, new drugs and treatment regimens as well as optimised dosing, provides the opportunity to share this new knowledge with relevant practitioners.
Seminar program, 26th February 2020
|
|
Topic |
Speaker |
|
|
0830-0900
|
Registration
|
|
|
|
0900-0910
|
Welcome
|
Prof Jason Roberts
The University of Queensland, QLD
|
|
|
0910-0940
|
Epidemiology of non-tuberculous mycobacteria the Australian and regional context
|
A/Prof Rachel Thomson
Gallipoli Medical Research Foundation, Greenslopes Private Hospital, QLD
|
|
|
0940-1010
|
Mycobacterium abscessus -when to treat, how to treat
|
Dr Andrew Burke
The Prince Charles Hospital, QLD
|
|
|
1010-1040
|
Clinical NTM treatment trials – current and planned
|
A/Prof Rachel Thomson
Gallipoli Medical Research Foundation, Greenslopes Private Hospital, QLD
|
|
|
1040-1100
|
Morning tea
|
|
|
|
1100-1130
|
Mycobacterial susceptibility testing in TB and NTM
|
Dr Chris Coulter
Pathology Queensland, QLD
|
|
|
1130-1150
|
The new TB drugs- bedaquiline, delaminind, pretomanid
|
|
Dr Markian Choptiany
Princess Alexandra Hospital, QLD
|
|
1150-1210
|
Progress in short course regimens in susceptible and resistant tuberculosis
|
Dr Philipp DuCross
Burnet Institute, VIC
|
|
|
1210-1240
|
Paediatric tuberculosis
|
Prof Ben Marais
University of Sydney
Children's Hospital at Westmead, NSW
|
|
|
1240-1330
|
Lunch
|
|
|
|
1330-1400
|
Pharmacokinetics of anti-mycobacterials in tuberculosis
|
Dr Andrew Burke
The Prince Charles Hospital, QLD
|
|
|
1400-1430
|
Innovations in pharmacokinetic studies for anti-mycobacterials
|
Dr Suzie Parker
The University of Queensland, QLD
|
|
|
1430-1500
|
TB meningitis- basic science and clinical trials
|
Dr Joseph Donovan Oxford University Clinical Research Unit, Vietnam and the University of Oxford, UK
|
|
|
1500-1530
|
Afternoon tea
|
|
|
|
1530-1600
|
Latent TB- advances in therapeutic options
|
Dr Justin Denholm
Victorian Tuberculosis Program, Melbourne Health, VIC
|
|
|
1600-1630
|
Rolling out TB treatment in PNG and Asia
|
Dr Suman Majumdar
Burnet Institute, VIC
|
|
|
1630-1700
|
Mycobacterium ulcerans - pathogenesis and treatment
|
A/Prof Dan O'Brien
Barwon Health/Médecins Sans Frontières, VIC
|
|
|
1700-1710
|
Close
|
Jason Roberts/Andrew Burke
|
|
Venue
University of Melbourne
Spencer Rd, Parkville VIC 3052
The following are recordings of the presentations delivered on the optimised treatment of mycobacterial infections held in Melbourne on 26 February 2020.
Morning session - Part 1
Mid-morning session - Part 2
Afternoon session - Part 3
Later afternoon session - Part 4